{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:17:52Z","timestamp":1793938672079,"version":"4.8.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.addr.2025.115594","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T06:14:02Z","timestamp":1746425642000},"page":"115594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead"],"prefix":"10.1016","volume":"222","author":[{"given":"E.Coulter","family":"Montague","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgehan","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Sefton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Wulkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal J.","family":"Alibhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5908-880X","authenticated-orcid":false,"given":"Michael A.","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2025.115594_b0005","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.addr.2025.115594_b0015","first-page":"e9349","article-title":"Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.addr.2025.115594_b0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"issue":"2018","key":"10.1016\/j.addr.2025.115594_b0025","first-page":"291","article-title":"Annual Data Report: Heart","volume":"18","author":"Colvin","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.addr.2025.115594_b0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2025.115594_b0035","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/nprot.2007.371","article-title":"Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction","volume":"2","author":"Laake","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2025.115594_b0040","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of Human Embryonic Stem Cell-Derived Cardiomyocytes Improves Myocardial Performance in Infarcted Rat Hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0050","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.121.053563","article-title":"In Vitro Matured Human Pluripotent Stem Cell\u2013Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts","volume":"145","author":"Dhahri","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0060","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2025.115594_b0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell\u2013derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2025.115594_b0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","article-title":"Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates","volume":"122","author":"Zhu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1183-3","article-title":"Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure","volume":"10","author":"Liao","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2025.115594_b0085","first-page":"239","article-title":"Intramyocardial Transplantation of Human iPS Cell\u2013Derived Cardiac Spheroids Improves Cardiac Function in HeartFailure Animals, JACC: Basic to Translational","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.addr.2025.115594_b0090","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCULATIONAHA.120.049497","article-title":"Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41556-022-00899-8","article-title":"Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors","volume":"24","author":"Poch","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.addr.2025.115594_b0105","doi-asserted-by":"crossref","unstructured":"L. Yap, Y.L. Chong, C. Tan, et al., Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs, npj Regenerative Medicine, 8 (2023). 10.1038\/s41536-023-00302-6.","DOI":"10.1038\/s41536-023-00302-6"},{"key":"10.1016\/j.addr.2025.115594_b0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.122.061736","article-title":"Combined Treatment of Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates","volume":"148","author":"Cheng","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.123.064876","article-title":"Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell\u2013Derived Cardiac Spheroids","volume":"150","author":"Kobayashi","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s44161-023-00419-3","article-title":"Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias","volume":"3","author":"Selvakumar","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.addr.2025.115594_b0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacbts.2023.11.005","article-title":"miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair","volume":"9","author":"Zhang","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.addr.2025.115594_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1374881","article-title":"Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias","volume":"11","author":"Wulkan","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.addr.2025.115594_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-025-10596-0","article-title":"Human Cardiac Microtissues Display Improved Engraftment and Survival in a Porcine Model of Myocardial Infarction","author":"Demkes","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.addr.2025.115594_b0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.stem.2023.04.010","article-title":"Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy","volume":"30","author":"Marchiano","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2025.115594_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2022.11.004","article-title":"Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration","volume":"174","author":"Kobayashi","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0150","unstructured":"International Clinical Trials Registry Platform (NCT04982081). Treating Congestive HF With hiPSC-CMs Through Endocardial Injection [(accessed October 7, 2024)]; Available online: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NCT04982081."},{"key":"10.1016\/j.addr.2025.115594_b0155","article-title":"Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I\/IIa dose-escalation clinical trial","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.addr.2025.115594_b0160","unstructured":"International Clinical Trials Registry Platform (JPRN-jRCTa032200189). Safety study of regenerative therapy with allogeneic induced pluripotent stem cell-derived cardiac spheres for severe heart failure - Regenerative cardiac spheres [(accessed October 7, 2024)]; Available at: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-jRCTa032200189."},{"key":"10.1016\/j.addr.2025.115594_b0165","unstructured":"International Clinical Trials Registry Platform (NCT04945018). A Phase I\/II Study of Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Severe Heart Failure, Secondary to Ischemic Heart Disease [(accessed October 7, 2024)]; Available at: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NCT04945018."},{"key":"10.1016\/j.addr.2025.115594_b0170","unstructured":"CenterWatch (NCT06340048). Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure [(accessed October 7, 2024)]; Available at: https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT06340048\/epicardial-injection-of-hipsc-cms-to-treat-severe-chronic-ischemic-heart-failure#location."},{"key":"10.1016\/j.addr.2025.115594_b0175","series-title":"Jianyi Zhang","first-page":"313","article-title":"Creating and Validating New Tools to Evaluate the Electrical Integration and Function of hPSC-Derived Cardiac Grafts In Vivo","author":"Dhahri","year":"2022"},{"key":"10.1016\/j.addr.2025.115594_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016734","article-title":"Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A","volume":"6","author":"Fujiwara","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2025.115594_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cardiores.2004.11.009","article-title":"Hematopoietic stem cells do not repair the infarcted mouse heart","volume":"65","author":"Deten","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2025.115594_b0190","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/mt.2008.64","article-title":"Adult Bone Marrow\u2013derived Cells Do Not Acquire Functional Attributes of Cardiomyocytes When Transplanted into Peri-infarct Myocardium","volume":"16","author":"Scherschel","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2025.115594_b0195","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13287-024-03826-w","article-title":"Protein-free media for cardiac differentiation of hPSCs in 2000mL suspension culture","volume":"15","author":"Kriedemann","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2025.115594_b0205","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13248","article-title":"Scalable manufacturing of clinical\u2010grade differentiated cardiomyocytes derived from human\u2010induced pluripotent stem cells for regenerative therapy","volume":"55","author":"Morita","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.addr.2025.115594_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2025.115594_b0215","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.120.047904","article-title":"Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner","volume":"143","author":"Querdel","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0220","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-024-08463-0","article-title":"Engineered heart muscle allografts for heart repair in primates and humans","volume":"639","author":"Jebran","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0225","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003918","article-title":"Phase I Clinical Trial of Autologous Stem Cell\u2013Sheet Transplantation Therapy for Treating Cardiomyopathy","volume":"6","author":"Miyagawa","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.addr.2025.115594_b0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of Human Embryonic StemCell\u2013Derived Cardiovascular Progenitors for SevereIschemic LeftVentricular Dysfunction","volume":"71","author":"Menasch\u00e9","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1182209","article-title":"Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports","volume":"10","author":"Kawamura","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.addr.2025.115594_b0240","unstructured":"International Clinical Trials Registry Platform (NCT04396899). Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-HF) [(accessed October 7, 2024)]; Available at: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NCT04396899."},{"key":"10.1016\/j.addr.2025.115594_b0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144068","article-title":"In vivo grafting of large engineered heart tissue patches for cardiac repair","volume":"6","author":"Jabbour","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2025.115594_b0250","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","article-title":"Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues","volume":"8","author":"Shadrin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2025.115594_b0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1018680900305","article-title":"The survival of embryonic cardiomyocytes transplanted into damaged host rat myocardium","volume":"18","author":"Connold","year":"1997","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.addr.2025.115594_b0260","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0003-4975(96)00389-X","article-title":"Cardiomyocyte Transplantation Improves Heart Function","volume":"62","author":"Li","year":"1996","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2025.115594_b0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.CIR.100.2.193","article-title":"Survival, Integration, and Differentiation of Cardiomyocyte Grafts","volume":"100","author":"Reinecke","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0270","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1006\/jmcc.2000.1391","article-title":"Influence of Embryonic Cardiomyocyte Transplantation on the Progression of Heart Failure in a Rat Model of Extensive Myocardial Infarction","volume":"33","author":"Etzion","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0275","article-title":"Can grafted cardiomyocytes colonize peri-infarct myocardial areas?","volume":"94","author":"Scorsin","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0280","article-title":"Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?","volume":"94","author":"Leor","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0285","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1172\/JCI118769","article-title":"Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts","volume":"98","author":"Klug","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.addr.2025.115594_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/658958","article-title":"Histologically Measured Cardiomyocyte Hypertrophy Correlates with Body Height as Strongly as with Body Mass Index","volume":"2011","author":"Tracy","year":"2011","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.addr.2025.115594_b0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9440(10)62041-X","article-title":"Formation of Human Myocardium in the Rat Heart from Human Embryonic Stem Cells","volume":"167","author":"Laflamme","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2025.115594_b0300","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2016.10.009","article-title":"InVivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts","volume":"8","author":"Kadota","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23329-z","article-title":"Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells","volume":"12","author":"Funakoshi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2025.115594_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03468-4","article-title":"Mature humaninduced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin","volume":"14","author":"Tanaka","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2025.115594_b0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yjmcc.2017.06.008","article-title":"Suppression of autophagic flux contributes to cardiomyocyte death by activation of necroptotic pathways","volume":"108","author":"Ogasawara","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0320","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.jtcvs.2014.06.087","article-title":"Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell\u2013derived cardiomyocytes","volume":"148","author":"Luo","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2025.115594_b0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.yjmcc.2010.09.008","article-title":"Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats","volume":"49","author":"Fernandes","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0330","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1074248413520344","article-title":"Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model","volume":"19","author":"Shiba","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2025.115594_b0335","doi-asserted-by":"crossref","unstructured":"N.A. Raval, G.E. Schmuck, S. Roy, et al., Human iPSC-derived Committed Cardiac Progenitors Generate Cardiac Tissue Grafts in a Swine Ischemic Cardiomyopathy Model without Triggering Ventricular Arrhythmias, bioRxiv, (2024). 10.1101\/2024.02.14.580375.","DOI":"10.1101\/2024.02.14.580375"},{"key":"10.1016\/j.addr.2025.115594_b0340","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","article-title":"Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies","volume":"33","author":"Zhang","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0345","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.119.044974","article-title":"Engrafted Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes Undergo Clonal Expansion In Vivo","volume":"143","author":"El-Nachef","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/rme.10.91","article-title":"Efficient Generation and Cryopreservation of Cardiomyocytes Derived from Human Embryonic Stem Cells","volume":"6","author":"Xu","year":"2011","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2025.115594_b0355","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-61779-201-4_31","article-title":"Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells","volume":"767","author":"Zhu","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.addr.2025.115594_b0360","article-title":"Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties","volume":"43","author":"Brink","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.addr.2025.115594_b0365","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1933719110385130","article-title":"Cryopreservation of Human Embryonic Stem Cells Derived-Cardiomyocytes Induced by BMP2 in Serum-Free Condition","volume":"18","author":"Kim","year":"2011","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.addr.2025.115594_b0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","article-title":"Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.addr.2025.115594_b0375","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nprot.2017.033","article-title":"Differentiation of cardiomyocytes and generation of human engineered heart tissue","volume":"12","author":"Breckwoldt","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2025.115594_b0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.scr.2018.08.015","article-title":"A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres","volume":"32","author":"Fischer","year":"2018","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.addr.2025.115594_b0385","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.5966\/sctm.2014-0294","article-title":"Concise Review: Process Development Considerations for Cell Therapy","volume":"4","author":"Campbell","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.addr.2025.115594_b0390","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jtcvs.2006.05.034","article-title":"Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty","volume":"132","author":"Teng","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.addr.2025.115594_b0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/jmcc.2001.1491","article-title":"Survival and Development of Neonatal Rat Cardiomyocytes Transplanted into Adult Myocardium","volume":"34","author":"M\u00fcller-Ehmsen","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0400","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cardiores.2005.04.011","article-title":"Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy","volume":"67","author":"Dow","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2025.115594_b0405","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yjmcc.2008.03.009","article-title":"Systems approaches to preventing transplanted cell death in cardiac repair","volume":"45","author":"Robey","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0410","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamacardio.2016.2750","article-title":"Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0415","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.athoracsur.2011.07.012","article-title":"Stem Cell Engraftment and Survival in the Ischemic Heart","volume":"92","author":"Wu","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.addr.2025.115594_b0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2015.04.139","article-title":"A temperature-sensitive, self-adhesive hydrogel to deliver iPSC-derived cardiomyocytes for heart repair","volume":"190","author":"Wang","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133308","article-title":"Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction","volume":"10","author":"Nakajima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2025.115594_b0435","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1038\/s41598-017-09217-x","article-title":"Impact of extracellular matrix on engraftment and maturation of pluripotent stem cell-derived cardiomyocytes in a rat myocardial infarct model","volume":"7","author":"Ogasawara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115594_b0440","doi-asserted-by":"crossref","first-page":"24459","DOI":"10.1021\/acsami.8b08659","article-title":"Folic Acid Derived Hydrogel Enhances the Survival and Promotes Therapeutic Efficacy of iPS Cells for Acute Myocardial Infarction","volume":"10","author":"Li","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2025.115594_b0445","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/jbm.a.36886","article-title":"Self\u2010healing injectable gelatin hydrogels for localized therapeutic cell delivery","volume":"108","author":"Sisso","year":"2020","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.addr.2025.115594_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121231","article-title":"Injectable AuNP-HA matrix with localized stiffness enhances the formation of gap junction in engrafted human induced pluripotent stem cell-derived cardiomyocytes and promotes cardiac repair","volume":"279","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2025.115594_b0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf2898","article-title":"Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts","volume":"9","author":"Tan","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2025.115594_b0460","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.1403","article-title":"Nongenetic method for purifying stem cell\u2013derived cardiomyocytes","volume":"7","author":"Hattori","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.addr.2025.115594_b0465","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.biomaterials.2013.02.022","article-title":"The use of aggregates of purified cardiomyocytes derived from human ESCs forfunctional engraftment after myocardial infarction","volume":"34","author":"Moon","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2025.115594_b0470","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020402","article-title":"All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.addr.2025.115594_b0475","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell-derived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.addr.2025.115594_b0480","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.7150\/thno.56757","article-title":"Thymosin \u03b24 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction","volume":"11","author":"Tan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2025.115594_b0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cvr\/cvy207","article-title":"Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice","volume":"115","author":"Zhao","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2025.115594_b0490","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stem.2019.01.013","article-title":"MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size InVivo","volume":"24","author":"Fiedler","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2025.115594_b0495","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ymthe.2022.08.012","article-title":"Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI","volume":"31","author":"Ai","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2025.115594_b0500","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41587-019-0197-9","article-title":"Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration","volume":"37","author":"Bargehr","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2025.115594_b0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2992","article-title":"Transplanted microvessels improve pluripotent stem cell\u2013derived cardiomyocyte engraftment and cardiac function after infarction in rats","volume":"12","author":"Sun","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2025.115594_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.03.003","article-title":"CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice","volume":"141","author":"Fan","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0515","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2019.09.011","article-title":"Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study","volume":"137","author":"Fan","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.addr.2025.115594_b0520","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCRESAHA.117.311504","article-title":"CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes","volume":"122","author":"Zhu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0525","doi-asserted-by":"crossref","unstructured":"I. Gruh, A. Martens, S. Cebotari, et al., Cell therapy with human iPSC-derived cardiomyocyte aggregates leads to efficient engraftment and functional recovery after myocardial infarction in non-human primates, bioRxiv, (2024). 10.1101\/2023.12.31.573775.","DOI":"10.1101\/2023.12.31.573775"},{"key":"10.1016\/j.addr.2025.115594_b0530","doi-asserted-by":"crossref","unstructured":"S.E. Silver, A.R. Howells, D.C. Arhontoulis, et al., Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair, bioRxiv, (2025). 10.1101\/2025.04.09.648007.","DOI":"10.1101\/2025.04.09.648007"},{"key":"10.1016\/j.addr.2025.115594_b0535","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of Allogeneic vs Autologous Bone Marrow\u2013Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2025.115594_b0540","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2025.115594_b0545","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction","volume":"63","author":"Malliaras","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0550","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0555","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCRESAHA.115.305373","article-title":"Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology","volume":"118","author":"Hodgkinson","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0560","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stemcell therapy","volume":"577","author":"Vagnozzi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0565","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pathol.2.010506.092038","article-title":"Cell-Based Therapy for Myocardial Ischemia and Infarction: Pathophysiological Mechanisms","volume":"2","author":"Laflamme","year":"2007","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.addr.2025.115594_b0570","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.122.060124","article-title":"Contractile Force of Transplanted Cardiomyocytes Actively Supports Heart Function After Injury","volume":"146","author":"St\u00fcdemann","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0575","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/cells11060951","article-title":"Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study","volume":"11","author":"Joshi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.addr.2025.115594_b0580","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.RES.83.5.516","article-title":"Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I","volume":"83","author":"Wang","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0585","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcp.10036","article-title":"Basic fibroblast growth factor protects cardiac myocytes from iNOS\u2010mediated apoptosis","volume":"190","author":"Iwai-Kanai","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2025.115594_b0590","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/CIRCULATIONAHA.114.015231","article-title":"Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes After Acute Myocardial Infarction","volume":"132","author":"Ong","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2025.115594_b0595","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41551-018-0229-7","article-title":"Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells","volume":"2","author":"Liu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2025.115594_b0600","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1318","article-title":"Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"12","author":"Gao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2025.115594_b0605","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","article-title":"Cardiovascular progenitor\u2013derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure","volume":"35","author":"Kervadec","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.addr.2025.115594_b0610","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.124.325133","article-title":"Noncontractile Stem Cell-Cardiomyocytes Preserve Post-Infarction Heart Function","volume":"135","author":"Karbassi","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0615","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13287-020-01919-w","article-title":"Optical mapping of human embryonic stem cell-derived cardiomyocyte graft electrical activity in injured hearts","volume":"11","author":"Filice","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2025.115594_b0620","first-page":"R391","article-title":"Effect of ambient temperature on cardiovascular parameters in rats and mice: a comparative approach, American Journal of Physiology-Regulatory, Integrative and Comparative","volume":"287","author":"Swoap","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.addr.2025.115594_b0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vascn.2006.04.008","article-title":"Methodological validation of an existing telemetry system for QT evaluation in conscious guinea pigs","volume":"55","author":"Shiotani","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.addr.2025.115594_b0630","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.yjmcc.2014.04.010","article-title":"Cell-based delivery of dATP via gap junctions enhances cardiac contractility","volume":"72","author":"Lundy","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0635","doi-asserted-by":"crossref","unstructured":"N.K. Mhatre, J. Mathieu, A. Martinson, et al., Cell based dATP delivery as a therapy for chronic heart failure, bioRxiv, (2023). 10.1101\/2023.04.24.538108.","DOI":"10.1101\/2023.04.24.538108"},{"key":"10.1016\/j.addr.2025.115594_b0640","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI200112131","article-title":"Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes","volume":"108","author":"Kehat","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.addr.2025.115594_b0645","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/biom14010061","article-title":"Casein Kinase 1 Phosphomimetic Mutations Negatively Impact Connexin-43 Gap Junctions in Human Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"14","author":"Al-Attar","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2025.115594_b0650","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nbt1014","article-title":"Electromechanical integration of cardiomyocytes derived from human embryonic stem cells","volume":"22","author":"Kehat","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2025.115594_b0655","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-1047-2_20","article-title":"Methods for Assessing the Electromechanical Integration of Human Pluripotent Stem Cell-Derived Cardiomyocyte Grafts","volume":"1181","author":"Zhu","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2025.115594_b0660","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00424-023-02869-x","article-title":"Modulating cardiac physiology in engineered heart tissue with the bidirectional optogenetic tool BiPOLES","volume":"475","author":"Schwarzov\u00e1","year":"2023","journal-title":"Pfl\u00fcgers Archiv - European Journal of Physiology"},{"key":"10.1016\/j.addr.2025.115594_b0665","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.stemcr.2024.06.012","article-title":"Impulse initiation in engrafted pluripotent stem cell-derived cardiomyocytes can stimulate the recipient heart","volume":"19","author":"St\u00fcdemann","year":"2024","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0670","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115594_b0675","first-page":"432","article-title":"A comparative anatomic and physiologic overview of the porcine heart","volume":"53","author":"Lelovas","year":"2014","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.addr.2025.115594_b0680","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000459725","article-title":"Heart Rate in Caged Macaca fascicularis","volume":"6","author":"Malinow","year":"1977","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.addr.2025.115594_b0685","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ajpa.22593","article-title":"Intra\u2010 and interspecific variation in macaque molar enamel thickness","volume":"155","author":"Kato","year":"2014","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.addr.2025.115594_b0690","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.123.321553","article-title":"Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar","volume":"134","author":"Donahue","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0695","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.rec.2012.03.022","article-title":"Ventricular Tachycardia in Coronary Artery Disease","volume":"65","author":"Benito","year":"2012","journal-title":"Revista Espa\u00f1ola De Cardiolog\u00eda (english Edition)"},{"key":"10.1016\/j.addr.2025.115594_b0700","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2021.08.011","article-title":"Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes","volume":"162","author":"Yu","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2025.115594_b0705","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1038\/s41598-019-45684-0","article-title":"A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115594_b0710","doi-asserted-by":"crossref","unstructured":"W. Li, L.J. Han, E. Entcheva, Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes, American Journal of Physiology-Heart and Circulatory Physiology, 319 (2020) H1112-H1122. 10.1152\/ajpheart.00148.2020.","DOI":"10.1152\/ajpheart.00148.2020"},{"key":"10.1016\/j.addr.2025.115594_b0715","doi-asserted-by":"crossref","unstructured":"B. Goversen, D.V.A.G.M. Heyden, V.A.B.T. Veen, et al., The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on I K1, Pharmacology & Therapeutics, 183 (2018) 127-136. 10.1016\/j.pharmthera.2017.10.001.","DOI":"10.1016\/j.pharmthera.2017.10.001"},{"key":"10.1016\/j.addr.2025.115594_b0720","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphys.2012.00346","article-title":"Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias","volume":"3","author":"Hoekstra","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.addr.2025.115594_b0725","first-page":"H2006","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents, American Journal of Physiology-Heart and Circulatory","volume":"301","author":"Ma","year":"2011","journal-title":"Physiology"},{"key":"10.1016\/j.addr.2025.115594_b0730","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2015.01.013","article-title":"Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells","volume":"81","author":"Kim","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.addr.2025.115594_b0735","doi-asserted-by":"crossref","first-page":"11883","DOI":"10.1038\/s41598-020-68373-9","article-title":"Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo","volume":"10","author":"Ichimura","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2025.115594_b0740","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000080317.92718.99","article-title":"Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac Myocytes","volume":"93","author":"He","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0745","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13287-023-03610-2","article-title":"JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes","volume":"14","author":"Liew","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.addr.2025.115594_b0750","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.stemcr.2018.07.007","article-title":"Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells","volume":"11","author":"Veevers","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0755","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.RES.0000142316.08250.68","article-title":"Functional adult myocardium in the absence of Na+-Ca2+ exchange: cardiac-specific knockout of NCX1","volume":"95","author":"Henderson","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2025.115594_b0760","article-title":"Acute Genetic Ablation of Cardiac Sodium\/Calcium Exchange in Adult Mice: Implications for Cardiomyocyte Calcium Regulation","volume":"10","author":"Lotteau","year":"2021","journal-title":"Cardioprotection, and Arrhythmia, Journal of the American Heart Association"},{"key":"10.1016\/j.addr.2025.115594_b0765","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1002\/cpz1.88","article-title":"Autologous Induced Pluripotent Stem Cell-Based Cell Therapies: Promise","volume":"1","author":"Madrid","year":"2021","journal-title":"Progress, and Challenges, Curr Protoc"},{"key":"10.1016\/j.addr.2025.115594_b0770","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12929-019-0578-x","article-title":"Human iPSC banking: barriers and opportunities","volume":"26","author":"Huang","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.addr.2025.115594_b0775","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nbt0708-739","article-title":"HLA-haplotype banking and iPS cells","volume":"26","author":"Nakatsuji","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.addr.2025.115594_b0780","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2025.115594_b0785","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2025.115594_b0790","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010239","article-title":"Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy","volume":"7","author":"Mattapally","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.addr.2025.115594_b0795","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301186","article-title":"HLA-E(high) \/HLA-G(high) \/HLA-II(low) Human iPSC-Derived Cardiomyocytes Exhibit Low Immunogenicity for Heart Regeneration","volume":"12","author":"Fang","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2025.115594_b0800","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.addr.2025.115594_b0805","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","article-title":"Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques","volume":"42","author":"Hu","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.addr.2025.115594_b0810","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41536-022-00242-7","article-title":"Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies","volume":"7","author":"Kim","year":"2022","journal-title":"NPJ Regen Med"},{"key":"10.1016\/j.addr.2025.115594_b0815","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcyt.2024.05.022","article-title":"Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee","volume":"26","author":"Madrid","year":"2024","journal-title":"Cytotherapy"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:15:44Z","timestamp":1748420144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X25000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":163,"alternative-id":["S0169409X25000791"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2025.115594","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2025.115594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115594"}}